Skip to content

Clinical trials

Phase 2 Squamous Cell Carcinoma of Head and Neck trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Squamous Cell Carcinoma of Head and Neck Phase: Phase 2 Country / region: South Korea Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20131
20141
20153
20173
20181
20192
20202
20217
20224
20235
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Active, not recruiting7
Terminated6
Unknown status5
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Yonsei University5
Seoul National University Hospital4
Merck Sharp & Dohme LLC3
ALX Oncology Inc.2
Kura Oncology, Inc.2
Pfizer2
AstraZeneca1
Bayer1
BeiGene1
Flamingo Therapeutics NV1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Squamous Cell Carcinoma of Head and Neck32
Head and Neck Neoplasms14
Esophageal Squamous Cell Carcinoma3
Recurrence3
Carcinoma, Non-Small-Cell Lung2
Melanoma2
Neoplasm Metastasis2
Small Cell Lung Carcinoma2
Uterine Cervical Neoplasms2
Anus Neoplasms1

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.